Last reviewed · How we verify
NCT05023746
Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer Patients
trial testing Genetron lung cancer panel in Non-Small Cell Lung Cancer in 1,052 participants. Completed in 17 September 2019.
9 September 2019
Quick facts
| Lead sponsor | Genetron Health |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,052 |
| Start date | 30 August 2018 |
| Primary completion | 9 September 2019 |
| Estimated completion | 17 September 2019 |
| Sites | 4 locations across China |
Drugs / interventions tested
- Genetron lung cancer panel
Conditions studied
- Non-Small Cell Lung Cancer — all drugs for Non-Small Cell Lung Cancer →
Sponsor
Genetron Health
Who can join
Eligibility, any sex, with Non-Small Cell Lung Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this trail is to evaluate the performance of Genetron lung cancer panel in non-small cell lung cancer patients using semiconductor sequencing method.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05023746
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Non-Small Cell Lung Cancer
Currently open trials in the same condition.
- NCT07140315 — DK222 Study at Hopkins · Phase 1 · recruiting
- NCT07487883 — Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors · recruiting
- NCT07413757 — CHOICE:Decision Factor of EGFR-TKI in Chinese IV NSCLC · recruiting
- NCT07460999 — Singing Training vs Usual Care 6-18 Months After Surgical Resection for Non-small Cell Lung Cancer (NSCLC) · NA · recruiting
- NCT07479277 — Progel Platinum for Air Leak Reduction After VATS Lobectomy for NSCLC · NA · recruiting
Other Genetron Health trials
Trials by the same sponsor.
- NCT05494853 — Novel Biomarker Assay for Biomarker Assay for HCC Detection · unknown
- NCT05395429 — Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients · unknown
- NCT05343832 — Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma Patients · unknown
- NCT05400018 — Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients · completed
- NCT05100602 — Clinical Evaluation of Genetron TERT PCR Kit in Glioma Patients · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05023746 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Genetron Health
- Last refreshed: 1 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05023746.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing